Impact of Bariatric Surgery in Obese Patients With and Without Obstructive Sleep Apnea Syndrome
Launched by RAMSAY GÉNÉRALE DE SANTÉ · Nov 25, 2019
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how bariatric surgery affects patients who are obese, especially those with a condition called obstructive sleep apnea (OSA). OSA is a serious sleep disorder where breathing repeatedly stops and starts during sleep, and it can lead to other health problems. The researchers want to see if patients with OSA experience different outcomes after surgery, such as improvements in heart health or the likelihood of complications compared to those without OSA.
To participate in this trial, you need to be over 18 years old and preparing for a type of bariatric surgery, like a gastric band, sleeve gastrectomy, or bypass, at the CELIOBE center. You also need to be part of a health insurance program. However, if you have already had bariatric surgery or are currently using a CPAP machine (a device to help with sleep apnea), you won't be eligible. If you join the study, you can expect to receive support and information throughout the process, helping researchers understand how bariatric surgery might affect your health differently based on sleep apnea status.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient, male or female, aged over 18
- • Patient in preparation for bariatric surgery (ring, Sleeve gastrectomy or Bypass) in the center CELIOBE.
- • Patient affiliated with social security or beneficiary of such a scheme
- • Patient having signed the free and informed consent
- Exclusion Criteria:
- • Patient who has already had bariatric surgery (ring, sleeve gastrectomy or bypass).
- • Patient already receiving CPAP treatment for sleep apnea syndrome.
- • Patients with pathology indicating the use of CPAP in self-guided mode (heart failure with altered ejection fraction) for patients diagnosed with OSAS
- • Patient likely, in the opinion of the investigator, not to be cooperative or respectful of the obligations inherent to participation in the study
- • Patient suffering from mental pathology does not make possible the collection of a consent.
- • Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- • Pregnant, lactating or parturient woman
- • Patient hospitalized without consent
About Ramsay Générale De Santé
Ramsay Générale de Santé is a leading private healthcare provider in France, dedicated to delivering high-quality medical services and advancing healthcare through innovative clinical research. With a robust portfolio of hospitals and clinics, the organization focuses on improving patient outcomes by conducting rigorous clinical trials across various therapeutic areas. Committed to enhancing healthcare solutions, Ramsay Générale de Santé collaborates with healthcare professionals, researchers, and pharmaceutical companies to facilitate groundbreaking studies that contribute to medical knowledge and patient care advancements. Their emphasis on patient safety, ethical standards, and scientific integrity underscores their role as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, Haut De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials